This Government Contract opportunity from Department Of Defense was posted on July 16, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Pharmaceutical Manufacturing and Formulation

Closed

Federal

Submission Closed07/22/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Supply of Dextrose Oral Gel (15g, Package of 3's)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Watermelon-Flavored Oral Rehydration Salts

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZOCAINE TOPICAL AER

Solicitation # SPE2DP-26-T-4782

This contract is for the procurement of Benzocaine 20 percent oral topical aerosol, provided in 2 fluid ounce containers. The item is regulated by the FDA and is manufactured by Beutlich Pharmaceuticals, LLC. It carries a non-extendable shelf life of 36 months and requires the submission of a Material Safety Data Sheet. Although not officially classified as hazardous, the item must be treated as hazardous material for handling purposes. All shipments must be delivered to the Defense Depot Susquehanna Site East in New Cumberland, Pennsylvania, within 20 days of order. Packaging and marking must strictly adhere to commercial standards and Medical Marking Standard No. 1. The contract specifies a quantity of one unit with a zero percent variance allowed, and inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4781

This contract is for the procurement of Dextrose Oral Gel, specifically 15 gram squeeze tubes with twist-off tips, provided in packages of three. The item is an FDA-regulated drug and must adhere to a non-extendable shelf life of 18 months, with at least 15 months remaining upon delivery to the government. All materials must be marked according to Medical Marking Standard No. 1 and packaged in sealed unit containers and commercial exterior shipping containers to ensure safe delivery. The order consists of one package under NSN 6505014253168, with delivery required within 20 days to the USS Zumwalt DDG 1000. Shipping must be handled via the fastest traceable means, specifically avoiding parcel post. The contract specifies that all packaging and palletization must comply with DLA packaging requirements and the DLA Master List of Technical and Quality Requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Health Sector Supply Chain Fragility and Investment Prioritization Support Services

Solicitation # 77344426S0002

The U.S. International Development Finance Corporation intends to award a one-year sole source purchase order to the API Innovation Center for specialized technical and analytical support. The objective is to identify and assess vulnerabilities within pharmaceutical and health-sector supply chains to uncover investment and resilience opportunities. The selected contractor will be responsible for producing national fragility analyses, integrating complex datasets regarding manufacturing and geopolitics, and preparing 20 to 30 drug-specific supply chain reports focusing on active pharmaceutical ingredients and upstream dependencies. This procurement action is being conducted under the authority of FAR 13.106-1(b). While the government intends to negotiate with a single source, interested vendors may submit responses to the contracting officer by August 31, 2026, at 4:30pm Eastern Time. The government will use these responses to determine whether to proceed with a sole source award or transition to a competitive procurement process.

Office Of Acquisition

POSTED

DEADLINE

6505--Rubidium Rb-82 Generator and Associated Supplies

Solicitation # 36C26127Q0032

The Department of Veterans Affairs, Network Contracting Office 21, intends to award a sole source delivery order to Bracco Diagnostics Inc. for the procurement of Rubidium Rb-82 generators, infusion system leasing, and associated consumables. This acquisition supports Cardiac PET imaging clinical operations at the VA Northern California Health Care System in Mather, California. The requirement is designated as a sole source because the equipment and elution system components are proprietary to Bracco Diagnostics Inc., the original equipment manufacturer. The scope of work includes the delivery of approximately nine generators per year, a 12-month infusion system lease, and various supplies such as accessory packs, waste bottles, elution test vials, and thermal printer paper to ensure compatibility with existing CardioGen 82 systems. The procurement falls under NAICS code 325412 for Pharmaceutical Preparation Manufacturing. To be eligible for participation, vendors must be an OEM, authorized dealer, distributor, or reseller and provide documentation proving such authority. Compliance with VAAR 852.212-71 and VAAR 852.212-72 regarding Gray Market and Counterfeit Items is mandatory. Interested parties must submit a capability statement, proposal, or quotation to the contracting officer by September 9, 2026, at 3:00 pm Pacific Standard Time.

261-NETWORK Contract Office 21 (36C261)

POSTED

DEADLINE

Script Center Relocation

Solicitation # PANDHA26P000046644

The Defense Health Agency is soliciting a combined contract under solicitation number PANDHA26P000046644 for the relocation of script center equipment. The project involves moving various assets across multiple military installations, including the relocation of two units within the Cherry Point Exchange in North Carolina, one unit from the Dyess AFB Exchange to the Dyess AFB Clinic in Texas, one unit and lockers from the Ft. Carson Exchange to the Ft. Carson Hospital in Colorado, and one unit and lockers from the Maxwell AFB Exchange in Alabama to the Walter Reed Exchange in Maryland. This opportunity is categorized under NAICS code 325412 and is open to all bidders as there is no set-aside used. The solicitation was posted on August 27, 2026, with a response deadline of September 10, 2026. Primary coordination for this requirement is managed by Sandra Kharan and Saera Khan out of the agency's office in Falls Church, Virginia.

Defense Health Agency

POSTED

DEADLINE

Dapagliflozin Tablets

Solicitation # SPE2D2-26-R-0018

POSTED

DEADLINE

Emergency Supply of Prescription PharmaceuticalsThe Government of Jamaica, through the National Health Fund, has issued a subcontract for the emergency supply of prescription pharmaceuticals. This agreement focuses on the procurement and delivery of prescription-grade drugs under urgent conditions, encompassing all necessary stages of the supply chain including sourcing, labeling, packaging, and distribution. All activities must be executed in strict compliance with established health authority standards to ensure safety and quality. The contract is categorized under NAICS code 325412 and was posted on August 26, 2026.

POSTED

DEADLINE

Pharmaceutical Packaging and Labeling ServicesThis subcontract for Pharmaceutical Packaging and Labeling Services involves the secondary packaging of finished Naproxen Sodium tablets into 100-count bottles or blister packs. The selected provider must ensure all packaging adheres to specific technical requirements and utilizes DLA-compliant labeling. The contract is issued by the Department of Defense under the Medical Supply Chain Pharm FSA and will be performed at Fort Drum, New York. Interested parties must respond by September 1, 2026, for this requirement categorized under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Contract Manufacturing for Naproxen Sodium TabletsThe Department of Defense, through the Medical Supply Chain Pharm FSA, is seeking a subcontractor for the full-scale manufacturing of Naproxen Sodium 550 mg tablets. The scope of work encompasses the entire production process, including blending, granulation, compression, and coating, with a strict requirement that all in-process quality control measures meet USP standards. This subcontract opportunity is associated with NAICS code 325412 and will be performed at Fort Drum, New York. The solicitation was posted on August 26, 2026, with a response deadline of September 1, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Rehydration Salts for Oral Solution (COTS Pharmaceutical)This subcontract involves the supply of commercial off-the-shelf rehydration salts for oral solution, identified by NSN 6505-01-646-2692. The products must meet OTC pharmaceutical standards and be packaged in units of 100 packets per package, with delivery terms set as FOB Destination. The requirement is issued by the Department of Defense through the Medical Supply Chain Pharm FSA, falling under NAICS code 325412. Performance is to take place in APO 96319-5000, with a response deadline of September 1, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 3 days

AI Contract Overview

The contract pertains to the manufacture of Bupivacaine Hydrochloride Injection, USP, 0.5%, in 50 mL vials, requiring full compliance with United States Pharmacopeia standards, FDA current Good Manufacturing Practices, and specific military packaging requirements. The product must meet rigorous quality and safety benchmarks to ensure suitability for use by military medical personnel. The manufacturing scope encompasses formulation, production, and packaging under strict regulatory oversight to guarantee consistency, sterility, and efficacy. All stages of production must adhere to cGMP guidelines and include documented validation and quality control procedures to satisfy both civilian and defense healthcare standards. The solicitation is issued as a subcontract under NAICS code 325412, which classifies pharmaceutical formulation and manufacturing activities. The place of performance is designated as Fort Bragg, North Carolina, with a response deadline of July 22, 2026, and the solicitation was posted on July 16, 2026. The contracting entity is the Department of Defense, specifically under the Medical Supply Chain Pharm FSA, indicating this is part of the military’s medical supply logistics framework. While no set-aside provisions are specified, the procurement is aimed at securing a reliable domestic source of this critical anesthetic for military medical operations, with full traceability and compliance required throughout the supply chain.